Shelly Heimfeld is an accomplished professional with a strong background in Developmental Biology and Biochemistry.

She holds a Ph.D. in Developmental Biology from the University of California, Irvine, and a Bachelor of Science in Biochemistry from the University of California, Los Angeles.

With extensive experience in the field, Shelly has held key roles in various prestigious organizations.

She currently serves as the Scientific Director for Cellular Therapy at Seattle Cancer Care Alliance, where she contributes significantly to the advancement of cellular therapies.

Previously, she was the EVP Manufacturing and Research at Nohla Therapeutics, showcasing her expertise in leading manufacturing processes and research endeavors.

Furthermore, Shelly has served as the Scientific Director at the Cell Processing Facility at Fred Hutchinson Cancer Research Center, illustrating her leadership in cutting-edge research facilities.

Her prior role as the Director of Biological Research at CellPro, Inc. highlights her diverse experience in overseeing biological research projects.

Overall, Shelly Heimfeld's career reflects a profound commitment to advancing cellular therapies and conducting impactful biological research.